Top

Published in:

01-04-2015 | Review

BI-RADS update for breast cancer caregivers

Authors: Emily L. Sedgwick, Lilian Ebuoma, Anthony Hamame, Kanchan Phalak, Lorell Ruiz-Flores, Tamara Ortiz-Perez, Karla A. Sepulveda

Published in: Breast Cancer Research and Treatment | Issue 2/2015

Abstract

This review will discuss changes relevant to breast cancer caregivers in the fifth edition of the Breast Imaging Reporting and Data System.

D’Orsi CJSE, Mendelson EB, Morris EA et al (2013) ACR BI-RADS^® Atlas, Breast Imaging Reporting and Data System. American College of Radiology, Reston

Venkatesan A, Chu P, Kerlikowske K, Sickles EA, Smith-Bindman R (2009) Positive predictive value of specific mammographic findings according to reader and patient variables. Radiology 250:648–657CrossRefPubMedCentralPubMed

Burnside ES, Ochsner JE, Fowler KJ et al (2007) Use of microcalcification descriptors in BI-RADS 4th edition to stratify risk of malignancy. Radiology 242:388–395CrossRefPubMed

Bent CK, Bassett LW, D’Orsi CJ, Sayre JW (2010) The positive predictive value of BI-RADS microcalcification descriptors and final assessment categories. Am J Roentgenol 194:1378–1383CrossRef

Berg WA, Arnoldus CL, Teferra E, Bhargavan M (2001) Biopsy of amorphous breast calcifications: pathologic outcome and yield at stereotactic biopsy. Radiology 221:495–503CrossRefPubMed

Liberman L, Abramson AF, Squires FB, Glassman JR, Morris EA, Dershaw DD (1998) The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories. Am J Roentgenol 171:35–40CrossRef

Lee CH (2004) Problem solving MR imaging of the breast. Radiol Clin North Am 42:919–934CrossRefPubMed

Leung JW, Sickles EA (2007) Developing asymmetry identified on mammography: correlation with imaging outcome and pathologic findings. Am J Roentgenol 188:667–675CrossRef

Mitka M (2007) New ultrasound “elasticity” technique may reduce need for breast biopsies. JAMA 297:455CrossRefPubMed

10.

Berg WA, Cosgrove DO, Dore CJ et al (2012) Shear-wave elastography improves the specificity of breast US: the BE1 multinational study of 939 masses. Radiology 262:435–449CrossRefPubMed

11.

Hooley RJ, Greenberg KL, Stackhouse RM, Geisel JL, Butler RS, Philpotts LE (2012) Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41. Radiology 265:59–69CrossRefPubMed

12.

Harvey JA, Nicholson BT, Lorusso AP, Cohen MA, Bovbjerg VE (2009) Short-term follow-up of palpable breast lesions with benign imaging features: evaluation of 375 lesions in 320 women. Am J Roentgenol 193:1723–1730CrossRef

13.

Graf O, Helbich TH, Hopf G, Graf C, Sickles EA (2007) Probably benign breast masses at US: Is follow-up an acceptable alternative to biopsy? Radiology 244:87–93CrossRefPubMed

14.

King V, Brooks JD, Bernstein JL, Reiner AS, Pike MC, Morris EA (2011) Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology 260:50–60CrossRefPubMed

15.

Kuhl CK, Schrading S, Strobel K, Schild HH, Hilgers RD, Bieling HB (2014) Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI. J Clin Oncol 32:2304–2310CrossRefPubMed

Title: BI-RADS update for breast cancer caregivers
Authors: Emily L. Sedgwick
Lilian Ebuoma
Anthony Hamame
Kanchan Phalak
Lorell Ruiz-Flores
Tamara Ortiz-Perez
Karla A. Sepulveda
Publication date: 01-04-2015
Publisher: Springer US
Published in: Breast Cancer Research and Treatment / Issue 2/2015
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-015-3332-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2015

Pnck overexpression in HER-2 gene-amplified breast cancer causes Trastuzumab resistance through a paradoxical PTEN-mediated process

Inhibition of BET proteins impairs estrogen-mediated growth and transcription in breast cancers by pausing RNA polymerase advancement

Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial

Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic

Revisiting the estrogen receptor pathway and its role in endocrine therapy for postmenopausal women with estrogen receptor-positive metastatic breast cancer

The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells

Keynote webinar | Spotlight on antibody–drug conjugates in cancer